Occlutech is a leading medical device company specializing in minimally invasive cardiac implants. Founded in Germany in 2003 and now operating with Swiss headquarters, it develops and commercializes devices for structural heart disease, including congenital defects, stroke prevention, and heart failure therapies. The company collaborates with healthcare professionals to design products like occluders and atrial flow regulators to improve patient outcomes across global markets. Occlutech emphasizes innovation, quality, and life-long support for physicians performing cardiovascular procedures.
No recent news for this company.